Alibaba Health Information Technology Limited
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, healthcare food, adult and famil… Read more
Alibaba Health Information Technology Limited (ALBBY) - Total Assets
Latest total assets as of September 2025: $23.26 Billion USD
Based on the latest financial reports, Alibaba Health Information Technology Limited (ALBBY) holds total assets worth $23.26 Billion USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Alibaba Health Information Technology Limited - Total Assets Trend (2004–2025)
This chart illustrates how Alibaba Health Information Technology Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Alibaba Health Information Technology Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Alibaba Health Information Technology Limited's total assets of $23.26 Billion consist of 58.0% current assets and 42.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 10.5% |
| Accounts Receivable | $2.07 Billion | 9.8% |
| Inventory | $1.42 Billion | 6.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $275.22 Million | 1.3% |
| Goodwill | $810.85 Million | 3.8% |
Asset Composition Trend (2004–2025)
This chart illustrates how Alibaba Health Information Technology Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Alibaba Health Information Technology Limited's current assets represent 58.0% of total assets in 2025, a decrease from 88.0% in 2004.
- Cash Position: Cash and equivalents constituted 10.5% of total assets in 2025, down from 57.4% in 2004.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, an increase from -1.0% in 2004.
- Asset Diversification: The largest asset category is accounts receivable at 9.8% of total assets.
Alibaba Health Information Technology Limited Competitors by Total Assets
Key competitors of Alibaba Health Information Technology Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cachet Pharmaceutical Co Ltd
SHE:002462
|
China | CN¥12.68 Billion |
|
Yunnan Hongxiang Yixintang
SHE:002727
|
China | CN¥15.84 Billion |
|
Luyan Pharma Co Ltd
SHE:002788
|
China | CN¥13.04 Billion |
|
Ji Yao Holding Group Co Ltd
SHE:300108
|
China | CN¥1.43 Billion |
|
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.
SHE:300937
|
China | CN¥1.75 Billion |
|
ShuYu Civilian Pharmacy Corp. Ltd.
SHE:301017
|
China | CN¥9.84 Billion |
|
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd
SHE:301126
|
China | CN¥6.56 Billion |
|
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
SHE:301408
|
China | CN¥5.26 Billion |
Alibaba Health Information Technology Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Alibaba Health Information Technology Limited generates 1.44x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Alibaba Health Information Technology Limited generates $6.76 in net profit.
Alibaba Health Information Technology Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.71 | 2.45 | 5.35 |
| Quick Ratio | 2.34 | 2.11 | 4.91 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $9.48 Billion | $ 7.04 Billion | $ 11.67 Billion |
Alibaba Health Information Technology Limited - Advanced Valuation Insights
This section examines the relationship between Alibaba Health Information Technology Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.92 |
| Latest Market Cap to Assets Ratio | 0.59 |
| Asset Growth Rate (YoY) | 7.5% |
| Total Assets | $21.18 Billion |
| Market Capitalization | $12.50 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Alibaba Health Information Technology Limited's assets below their book value (0.59 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Alibaba Health Information Technology Limited's assets grew by 7.5% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Alibaba Health Information Technology Limited (2004–2025)
The table below shows the annual total assets of Alibaba Health Information Technology Limited from 2004 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | $21.18 Billion | +7.48% |
| 2024-03-31 | $19.71 Billion | -5.02% |
| 2023-03-31 | $20.75 Billion | +8.05% |
| 2022-03-31 | $19.20 Billion | +8.25% |
| 2021-03-31 | $17.74 Billion | +125.40% |
| 2020-03-31 | $7.87 Billion | +31.56% |
| 2019-03-31 | $5.98 Billion | +92.28% |
| 2018-03-31 | $3.11 Billion | +85.21% |
| 2017-03-31 | $1.68 Billion | +24.59% |
| 2016-03-31 | $1.35 Billion | -4.30% |
| 2015-03-31 | $1.41 Billion | +260.21% |
| 2014-03-31 | $391.08 Million | +6.75% |
| 2013-03-31 | $366.36 Million | -16.10% |
| 2012-03-31 | $436.68 Million | -8.52% |
| 2011-03-31 | $477.37 Million | -4.59% |
| 2010-03-31 | $500.33 Million | -5.91% |
| 2009-03-31 | $531.78 Million | -26.27% |
| 2008-03-31 | $721.22 Million | -22.68% |
| 2007-03-31 | $932.82 Million | -10.40% |
| 2006-03-31 | $1.04 Billion | +118.41% |
| 2005-03-31 | $476.66 Million | +14.22% |
| 2004-03-31 | $417.33 Million | -- |